Antares Pharma Inc. (ATRS)

3.46
NASDAQ : Health Technology
Prev Close 3.46
Day Low/High 3.41 / 3.48
52 Wk Low/High 2.53 / 3.96
Avg Volume 814.40K
Exchange NASDAQ
Shares Outstanding 163.06M
Market Cap 564.19M
P/E Ratio N/A
Div & Yield N.A. (N.A)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Antares Pharma, Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Antares Pharma, Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Antares Pharma, Inc.

The Klein Law Firm announces the commencement of an investigation of Antares Pharma, Inc.

Stocks Under $10 Weekly Summary

We used price declines to scale into several holdings as small-caps underperformed the overall market.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Antares Pharma, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Antares Pharma, Inc.

The Klein Law Firm announces the commencement of an investigation of Antares Pharma, Inc.

ATRS INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Antares Pharma, Inc.

ATRS INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Antares Pharma, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Antares Pharma, Inc.

ATRS SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Antares Pharma, Inc.

ATRS SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Antares Pharma, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Antares Pharma, Inc.

Downgrading Antares Pharma, Cutting the Price Target

We are cutting the rating to Three from One.

Stocks Under $10 Weekly Summary

This week brings earnings from 5 portfolio holdings as the market continues to shrug off potential negatives.

Stocks Under $10 Weekly Summary

We took some profits and added a Bullpen name, among other moves, during a rough week for a few portfolio names.

How We're Playing AcelRx, Antares, AXI and Hudson Tech

Checking out some tough calls.

Stocks Under $10 Weekly Summary

We added to one name during a stellar week for the majority of the portfolio.

Recent Tech Big-Cap Laggards Finally Gain Some Attention

Recent Tech Big-Cap Laggards Finally Gain Some Attention

Money is flowing back into the FANG names and into Microsoft in particular while small-caps slow a bit.

Biotech Names Flexing Their Muscles

Biotech Names Flexing Their Muscles

There's action in Global Blood Therapeutics and Antares Pharma.

Stocks Under $10 Weekly Summary

We took a healthy profit trimming one name and added to three other positions last week.

Stocks Under $10 Weekly Summary

We added a digital security name to the Bullpen during a mixed week for the portfolio.

Stocks Under $10 Weekly Summary

We initiated 2 new positions and jettisoned another over the last week.

Stocks Under $10 Weekly Summary

We remain cautious during this historically volatile month for the market.

Stocks Under $10 Weekly Summary

We scaled into one position during a week dominated by Hurricane Harvey and its aftermath.

Stocks Under $10 Weekly Summary

We initiated 2 small positions last week as the market moved higher.

Commit To Purchase Antares Pharma At $2.50, Earn 42.4% Annualized Using Options

Commit To Purchase Antares Pharma At $2.50, Earn 42.4% Annualized Using Options

Investors considering a purchase of Antares Pharma Inc. shares, but tentative about paying the going market price of $3.06/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Stocks Under $10 Weekly Summary

We used last week's weakness to scale into several positions.

TheStreet Quant Rating: C (Hold)